Table 3.
Comorbid conditions in 5% or more of the study population.
| Comorbidity, n (%) | Patients (N = 113) |
|---|---|
| Hypertension or blood pressure increased | 71 (62.8) |
| Diabetes mellitus | 31 (27.4) |
| Benign prostatic hyperplasia or prostatomegaly | 26 (23.0) |
| Hypercholesterolemia or blood cholesterol increased | 26 (23.0) |
| Arthritis, osteoarthritis, or spinal osteoarthritis | 23 (20.4) |
| Coronary artery disease | 23 (20.4) |
| Hyperlipidemia or dyslipidemia | 21 (18.6) |
| Hematuria | 16 (14.2) |
| Chronic obstructive pulmonary disease or emphysema | 15 (13.3) |
| Depression | 12 (10.6) |
| Gastroesophageal reflux disease | 12 (10.6) |
| Nocturia | 12 (10.6) |
| Drug hypersensitivity | 11 (9.7) |
| Urinary tract infection | 11 (9.7) |
| Atrial fibrillation | 10 (8.8) |
| Erectile dysfunction | 10 (8.8) |
| Hypothyroidism, hyperthyroidism, or other thyroid disorder | 10 (8.8) |
| Prostate cancer | 9 (8.0) |
| Renal cyst | 8 (7.1) |
| Peripheral vascular disorder | 7 (6.2) |
| Glaucoma | 6 (5.3) |
| Gout | 6 (5.3) |
| Micturition urgency | 6 (5.3) |
| Pollakiuria | 6 (5.3) |